the best place to get tirzepatide Where Injection for Weight Loss in Scottsdale AZ Compounded Tirzepatide Top Tips -

With less NAD available, cells may have a harder time making energy and repairing damage

Tirzepatide represents a dual-action GLP-1 and GIP receptor agonist that has demonstrated weight loss outcomes of 20-22% in clinical trials when dosed appropriately

Call us for a free consultation

One of those dual agonists, tirzepatide (Mounjaro/Zepbound, Eli Lilly), was associated with a mean 14.7% weight loss for adults with overweight or obesity and type 2 diabetes in the SURMOUNT-2 trial compared with a 3.2% weight loss with placebo

It runs about 6% on the high-dose 7.2 mg Wegovy shot, but only around 3% on the 25 mg pill, which keeps it just under the 5% mark for the tablet

It belongs to the class of GLP-1 receptor agonists and works by suppressing appetite, making it easier for individuals to manage their caloric intake and shed those extra pounds